期刊文献+

隐丹参酮制剂对肝性脑病大鼠的保护作用研究 被引量:1

The protective effect of cryptotanshinone preparations on rats with hepatic encephalopathy
原文传递
导出
摘要 目的考察隐丹参酮制剂对肝性脑病大鼠的保护作用。方法SD大鼠随机分为正常组、模型组、谷氨酸片(360 mg/kg)组(阳性对照)、隐丹参酮高剂量(180 mg/kg)组、隐丹参酮中剂量(60 mg/kg)组、隐丹参酮低剂量(20mg/kg)组,每组10只。通过四氯化碳(CCl4)诱导慢性肝损伤伴高血氨模型、门腔静脉侧-侧分流术致大鼠肝性脑病模型,观察隐丹参酮对血清中丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、总胆红素(TBIL)、总蛋白(TP)、白蛋白(ALB)水平影响,以及对血氨、脑组织氨含量、肝脏组织病理学的影响。结果在CCl4致大鼠慢性肝损伤伴高血氨模型中,与模型组比较,隐丹参酮中剂量组可显著降低血氨水平(P<0.05),隐丹参酮高剂量组能明显降低血氨及脑组织氨水平(P<0.05),且能改善大鼠肝功能,降低血清中AST和ALP水平,差异均有统计学意义(P<0.05);隐丹参酮中、高剂量组可改善肝组织变性、减轻肝坏死。在门腔静脉侧-侧分流术致大鼠肝性脑病模型中,与模型组比较,隐丹参酮中、高剂量组及谷氨酸片组血氨和脑组织氨水平明显降低(P<0.05),且隐丹参酮高剂量组能改善肝脏功能,降低模型大鼠血清中ALT、ALP、TBIL水平,差异均有统计学意义(P<0.05),且隐丹参酮中、高剂量组能减轻肝组织变性、炎症、坏死。结论隐丹参酮制剂对肝性脑病大鼠具有一定保护作用。 Objective To investigate the protective effect of cryptotanshinone preparations on rats with hepatic encephalopathy.Methods SD rats were randomly divided into normal group,model group,positive glutamate tablet(360 mg/kg)group,cryptotanshinone high-dose(180 mg/kg)group,cryptotanshinone medium-dose(60 mg/kg)group,cryptotanshinone low-dose(20 mg/kg)group,with 10 rats in each group.Hepatic encephalopathy animal models were induced by carbon tetrachloride and side-to-side portal-caval shunt surgery.The effects of cryptotanshinone were measured by detecting the content of alanine aminotransferase(ALT),aspartate aminotransferase(AST),alkaline phosphatase(ALP),total bilirubin(TBIL),total protein(TP),albumin(ALB)in the serum and brain tissue ammonia content.HE staining of liver tissue and histopathological examination were measured.Results In chronic liver injury with high blood ammonia rats caused by CCl4,the high and middle doses of cryptotanshinone could significantly reduce blood ammonia and brain tissue ammonia levels(P<0.05).The high dose of cryptotanshinone could improve liver function and reduce serum AST and ALP contents in in rats(P<0.05).In hepatic encephalopathy rats caused by side-to-side portal-caval shunt surgery,cryptotanshinone could reduce blood ammonia and brain tissue ammonia levels(P<0.05);cryptotanshinone could also improve nerve reflex,reduce animal mortality,improve liver function pathological damage.Conclusion The cryptotanshinone played an important role in protecting rats from hepatic encephalopathy.
作者 陈宜林 周杭 路静 黄世亮 许元生 宋燕 刘培庆 陈健文 CHEN Yi-lin;ZHOU Hang;LU Jing;HUANG Shi-liang;XU Yuan-sheng;SONG Yan;LIU Pei-qing;CHEN Jian-wen(School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou,Guangdong 510006;Guangzhou Healthinlink Medical Technology Company,Guangzhou,Guangdong 510000,China)
出处 《热带医学杂志》 CAS 2021年第4期408-412,I0002,共6页 Journal of Tropical Medicine
基金 广东省医学科学基金(A2016148) 广东省本土创新科研团队项目(2017BT01Y093)。
关键词 隐丹参酮 肝性脑病 四氯化碳 高血氨 Cryptotanshinone Hepatic encephalopathy Carbon tetrachloride Hyperammonemia
  • 相关文献

参考文献4

二级参考文献26

  • 1Lindisley Ferreira Gomides,Pedro Elias Marques,Bruno Engler Faleiros,Rafaela Vaz Pereira,Sylvia Stella Amaral,Thais Reis Lage,Gustavo Henrique Souza Resende,Patricia Alves Maia Guidine,Giselle Foureaux,Fabíola Mara Ribeiro,Fabiana Paiva Martins,Marco Antonio Peliky Fontes,Anderson José Ferreira,Remo Castro Russo,Mauro Martins Teixeira,Márcio Flávio Moraes,Antonio Lúcio Teixeira,Gustavo Batista Menezes.Murine model to study brain,behavior and immunity during hepatic encephalopathy[J].World Journal of Hepatology,2014,6(4):243-250. 被引量:2
  • 2Pan RL,Xiang LX,Wang P,et al.Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic downregulation of Delta-like1[J].Hepatology,2015,61(5):1708-1720.
  • 3Chen L,Li J,Zhang J,et al.S100A4 promotes liver fibrosis via activation of hepatic stellate cells[J].J Hepatol,2015,62(1):156-164.
  • 4Krizhanovsky V,Yon M,Dickins RA,et al.Senescence of activated stellate cells limits liver fibrosis[J].Cell,2008,134(4):657-667.
  • 5Kong X,Feng D,Wang H,et al.Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice[J].Hepatology,2012,56(3):1150-1159.
  • 6Ritze Y,Bárdos G,Hubert A,et al.Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice[J].Br J Nutr,2014,112(1):1-7.
  • 7Jiang X,Guo H,Shen T,et al.Cyanidin-3-O-β-glucoside Purified from Black Rice Protects Mice against Hepatic Fibrosis Induced by Carbon Tetrachloride via Inhibiting Hepatic Stellate Cell Activation[J].J Agric Food Chem,2015,63(27):6221-6230.
  • 8Hemmann S,Graf J,Roderfeld M,et al.Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies[J].J Hepatol,2007,46(5):955-975.
  • 9Arauz J,Rivera E,Shibayama M,et al.Nicotinic acid prevents experimental liver fibrosis by attenuating the prooxidant process[J].Int Immunopharmacol,2015,28(1):244-251.
  • 10刘树军,黄静娟,车念聪.活血化痰基础方对大鼠非酒精性脂肪肝模型CYP2E1活性的影响[J].中西医结合肝病杂志,2008,18(2):109-111. 被引量:20

共引文献18

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部